The World Health Organization today announced the end of the Ebola outbreak in the Democratic Republic of the Congo. Shortly after the outbreak was declared in May, the African nation began offering health workers and other high-risk populations an experimental vaccine that was highly protective against the virus in a large 2015 trial in Guinea, assisted by the World Health Organization, Centers for Disease Control and Prevention and other partners. “The outbreak was contained due to the tireless efforts of local teams, the support of partners, the generosity of donors, and the effective leadership of the Ministry of Health,” said WHO Director-General Tedros Adhanom Ghebreyesus. “That kind of leadership, allied with strong collaboration between partners, saves lives.” The May outbreak was the ninth in the African nation since Ebola was discovered there in 1976.

Related News Articles

Headline
The Food and Drug Administration yesterday approved the first FDA-approved vaccine to prevent Ebola in adults with Zaire ebolavirus, which killed more…
Headline
The Food and Drug Administration last week authorized marketing of a rapid diagnostic test to detect Ebola virus antigens in human blood from certain living…
Headline
The Department of Health and Human Services yesterday awarded $20.5 million to develop vaccine candidates for Marburg virus and Sudan ebolavirus, which…
Headline
The World Health Organization recently deployed a rapid response team and personal protective equipment to the United Republic of Tanzania following unofficial…
Headline
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response will provide $23 million for Merck to produce…
Headline
Patients receiving either of two investigational treatments for Ebola in the Democratic Republic of the Congo had a greater chance of survival than those…